John Pacifico
General Partner, COO + CFO / East Coast
Since 2018
With experience as a venture capitalist and a CEO of two healthcare technology companies, John brings a wide-ranging perspective to Canaan. John initially joined Canaan in 2000 as a healthcare investor and served interim roles in Canaan portfolio companies over several years before being named CEO of Abyrx (formerly Orthocon) in 2010.
John is on the boards of directors at Abyrx, Aceiss, Axcelius I/II, Transposon Therapeutics and OncoLinea Pharmaceuticals. He is also the co-founder and chairman of the board at Kairuku, Inc., a SaaS solution for medical product distributors engaging with hospitals and surgery centers. John received a B.S. degree from Fairfield University, a MBA from Columbia Business School and is a Kauffman Fellow.
John in 5
Sport: Baseball - any team with players who work hard & love the game
Family: Stacy, Annalyn, Max and puppy Cal
Interests: Spending time with my family
Accomplishments: Invented new medical products that are FDA-cleared for use during surgical procedures
Bucket List: Seeing my team at Kairuku succeed
John in 5
Sport: Baseball - any team with players who work hard & love the game
Family: Stacy, Annalyn, Max and puppy Cal
Interests: Spending time with my family
Accomplishments: Invented new medical products that are FDA-cleared for use during surgical procedures
Bucket List: Seeing my team at Kairuku succeed